Jessica Mann to leave Evolva and join Roche
Jessica Mann was clinical advisor of Evolva from February 2008 until October 2009 when she became Chief Medical Officer and she has been instrumental in the planning and implementation of Evolva’s clinical activities during this period. As of 1 August 2010, Dr Mann will become a member of the Clinical Advisory Board of Evolva. At Roche, Dr Mann will lead the team in charge of early clinical development activities for the Metabolic DTA.
Dr Alexandra Sorensen will continue as overall responsible for the combined pre-clinical and clinical activities at Evolva. The company has initiated the recruitment of a new Chief Medical Officer.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.